Note the time: 12 noon ET
(6 p.m. in Amsterdam)
Join fellow WMers for a report on the Canadian results from the
Waldenström’s Macroglobulinemia VOICE study
Dr. Josephine Vos
Dr. Anne-Marie Becking
Researchers Drs. Vos and Becking will report on their patient-driven project designed to identify treatment preferences of patients with WM:
- Learn what 1455 WM patients from Canada, the US, the UK, Australia and the Netherlands prioritized about treatment efficacy, side effects and administration.
- Get a zoomed-in view of the Canadian demographics and results
- Discover how the results of this study may guide future drug development, inform clinical trial design, and improve shared decision-making in clinical practice.
